Related Experiment Video
Updated: May 22, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Clinical Outcomes and Quality of Life in Children with Central Precocious Puberty: A Pragmatic Analysis
Parikshit Sen1, Aashima Dabas1, Ravindra Kumar2
1Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.
Insights
Central precocious puberty (CPP) treatment with gonadotropin releasing hormone analog (GnRHa) leads to favorable growth and normal puberty resumption. Early GnRHa therapy is linked to better quality of life outcomes in children with CPP.
Area of Science:
- Pediatric Endocrinology
- Reproductive Medicine
- Child Growth and Development
Background:
- Central precocious puberty (CPP) presents variable growth and pubertal outcomes influenced by treatment. Understanding these outcomes is crucial for optimizing therapeutic strategies.
- Assessing the impact of gonadotropin releasing hormone analog (GnRHa) therapy on anthropometric measures and pubertal progression in children with CPP is essential.
Purpose of the Study:
- To evaluate growth and pubertal progression in children with CPP undergoing GnRHa therapy.
- To correlate treatment outcomes with the quality of life in children with CPP.
Main Methods:
- An observational study involving children with CPP treated with GnRHa.
- Collection of baseline and follow-up clinical data, including anthropometric measurements and pubertal status.
- Quality of life assessment using the PedsQL 4.0 questionnaire at the final follow-up visit.
Main Results:
- A cohort of 23 children (21 girls, 2 boys) with CPP was studied, with a median follow-up of 4.4 years.
- Treatment completion resulted in normal pubertal progression for 12 children. The bone age to chronological age ratio significantly decreased (p < 0.001).
- Earlier GnRHa therapy initiation correlated with improved growth velocity (r = -0.598; p = 0.003). Quality of life scores were generally favorable but lower in shorter, older, or post-menarcheal girls.
Conclusions:
- GnRHa therapy leads to favorable anthropometric outcomes and normal puberty resumption in children with CPP.
- Early and adequate GnRHa treatment is associated with positive quality of life outcomes in this pediatric population.
Objectives:
Variable anthropometric and pubertal outcomes are reported in children with central precocious puberty (CPP) based on treatment choices and practices. We aimed to measure growth and pubertal progression in these children and associate with quality of life in relation to therapy received.
Methods:
This observational study enrolled children with CPP who were receiving/had received gonadotropin releasing hormone analog (GnRHa). The baseline and follow-up clinical details were recorded. Quality of life was assessed using PedsQL 4.0 at the last follow up visit.
Results:
Twenty-three children (21girls, 2 boys) with CPP, having a median (IQR) age of 6.75 (5.23, 8.25) years were enrolled. The mean (SD) height SDS was 0.45 (1.20) and BMI-SDS 0.65 (1.06). The median (IQR) follow-up duration was 4.4 (2.5-5.1) years. Twelve children completed their treatment and progressed through puberty normally.Mean bone age/chronological age (BA/CA) ratio decreased from baseline 1.46 to 1.23 at follow-up, p < 0.001. A significant negative correlation was seen between age of start of GnRH therapy and growth velocity on follow-up (r = - 0.598; p = 0.003). The mean (SD) PedsQL scores for total, psychosocial and physical health were 59.02 (22.76), 58.41 (22.83), and 60.73 (25.56), respectively, with lower scores in shorter, older and post-menarcheal girls (p > 0.05).
Conclusion:
Our study found favorable anthropometric outcomes with resumption of normal puberty after completion of GnRH therapy. The quality of life outcomes were favorable with early and adequate GnRH therapy.
Related Concept Videos
Signs of Puberty
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Nature and Nurture
Conduct Disorder
Socioemotional Experience and Gender Development
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

